Efficacy and Safety of Adjunctive Levetiracetam Therapy in Pediatric Intractable Epilepsy

Pediatric Neurology

Volumn 42, Issue 2, 2010, Pages 86-92

  Lee, Yun Jin ^a   Kang, Hoon Chul ^a   Kim, Heung Dong ^a   Lee, Joon Soo ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ETIRACETAM;

ADOLESCENT; ADULT; ARTICLE; CHILD; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; EPILEPSY; FEMALE; HUMAN; INTRACTABLE EPILEPSY; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEIZURE;

ADOLESCENT; AGE FACTORS; AGGRESSION; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; HUMANS; INFANT; IRRITABLE MOOD; MALE; PIRACETAM; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 73649138277     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2009.08.002     Document Type: Article

References (22)

1. Callenbach P.M., Arts W.F., ten Houten R., et al. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study. Eur J Paediatr Neurol 12 (2008) 321-327
2. Lynch B.A., Lambeng N., Nocka K., et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A 101 (2004) 9861-9866
3. Patsalos P.N. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther 85 (2000) 77-85
4. Pellock J.M., Glauser T.A., Bebin E.M., et al. Pharmacokinetic study of levetiracetam in children. Epilepsia 42 (2001) 1574-1579
5. Opp J., Tuxhorn I., May T., et al. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany. Seizure 14 (2005) 476-484
6. Grosso S., Cordelli D.M., Franzoni E., et al. Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy. Seizure 16 (2007) 345-350
7. Tan M.J., and Appleton R.E. Efficacy and tolerability of levetiracetam in children aged 10 years and younger: a clinical experience. Seizure 13 (2004) 142-145
8. Lagae L., Buyse G., and Ceulemans B. Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial. Seizure 14 (2005) 66-71
9. Grosso S., Franzoni E., Coppola G., et al. Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy. Seizure 14 (2005) 248-253
10. Peake D., Mordekar S., Gosalakkal J., et al. Retention rate of levetiracetam in children with intractable epilepsy at 1 year. Seizure 16 (2007) 185-189
11. Glauser T.A., Ayala R., Elterman R.D., et al. N159 Study Group. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 66 (2006) 1654-1660
12. International League Against Epilepsy. Commission on Classification and Terminology. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22 (1981) 489-501
13. Krakow K., Walker M., Otoul C., and Sander J.W. Long-term continuation of levetiracetam in patients with refractory epilepsy. Neurology 56 (2001) 1772-1774
14. von Stuelpnagel C., Holthausen H., and Kluger G. Long-term use of levetiracetam in patients with severe childhood-onset epilepsy. Eur J Paediatr Neurol 11 (2007) 341-345
15. Nicolson A., Lewis S.A., and Smith D.F. A prospective analysis of the outcome of levetiracetam in clinical practice. Neurology 63 (2004) 568-570
16. Perry M.S., and Benatar M. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review. Epilepsia 48 (2007) 1123-1127
17. Betts T., Waegemans T., and Crawford P. A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy. Seizure 9 (2000) 80-87
18. Privitera M. Efficacy of levetiracetam: a review of three pivotal clinical trials. Epilepsia 42 Suppl. 4 (2001) 31-35
19. Shorvon S.D., Löwenthal A., Janz D., Bielen E., and Loiseau P. European Levetiracetam Study Group. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. Epilepsia 41 (2000) 1179-1186
20. Cereghino J.J., Biton V., Abou-Khalil B., Dreifuss F., Gauer L.J., and Leppik I. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology 55 (2000) 236-242
21. Mula M., Trimble M.R., and Sander J.W. Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam. Seizure 13 (2004) 55-57
22. Nakken K.O., Eriksson A.S., Lossius R., and Johannessen S.I. A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy. Seizure 12 (2003) 42-46